Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.14
-0.50 (-2.83%)
Sep 10, 2026, 11:59 AM HKT

HKG:1877 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,7322,6152,5023,7885,9973,507
Short-Term Investments
----17.93-
Trading Asset Securities
963.89600.78430.51---
Cash & Short-Term Investments
3,6963,2162,9333,7886,0153,507
Cash Growth
5.39%9.65%-22.58%-37.02%71.53%3.59%
Accounts Receivable
743.75506.75509.82483.23232.731,301
Other Receivables
122.27-36.44374.0178.8128.05
Receivables
866.02506.75546.26857.23314.251,329
Inventory
498.82573.11584.47538.05599.02484.6
Prepaid Expenses
----239.82-
Other Current Assets
144.24162.01220.38387.5936.94524.79
Total Current Assets
5,2054,4584,2845,5717,2055,845
Property, Plant & Equipment
5,1264,8724,1953,8093,2782,801
Long-Term Investments
2,7201,9141,2261,1331,2921,485
Other Intangible Assets
541.9559.77521.41546.9698.91264.98
Long-Term Deferred Tax Assets
86.3488.3187.05103.4228.4388.55
Long-Term Deferred Charges
-9.766.1212.6-27.79
Other Long-Term Assets
522.16480.35461.94167.14473.39522.34
Total Assets
14,20212,38210,78211,34312,57611,035

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,11373.99115.9125.19370.2363.17
Accrued Expenses
208.83804.98901.441,046917.211,603
Short-Term Debt
742.24603.2678.11452.44391.75-
Current Portion of Long-Term Debt
699.89659.39216.586.96-10.6
Current Portion of Leases
-32.0130.2935.9343.6634.47
Current Income Taxes Payable
30.084.7612.4117.98-63.08
Current Unearned Revenue
62.0122.188.17146.30.4445.8
Other Current Liabilities
34.67577.77531.11527.9250.96181.59
Total Current Liabilities
2,8912,7782,4942,4381,7742,001
Long-Term Debt
4,4192,7941,9801,196839.58490
Long-Term Leases
52.3756.6226.3117.4546.5993.13
Long-Term Unearned Revenue
157.13167.17181.91183.46121.62122.46
Other Long-Term Liabilities
530.08530.06168187.15-11.5
Total Liabilities
8,0506,3264,8504,0222,7822,719

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,0271,027985.69985.69982.87910.76
Additional Paid-In Capital
16,30716,41715,40715,395-11,423
Retained Earnings
-11,195-11,216-10,341-9,060--4,389
Treasury Stock
-30.89-30.89-30.89-26.89--
Comprehensive Income & Other
-164.7-166.69-159.94-142.078,5190.21
Total Common Equity
5,9446,0305,8607,1519,5017,945
Minority Interest
207.7326.1671.71169.39292.83371.28
Shareholders' Equity
6,1516,0575,9327,3219,7948,316
Total Liabilities & Equity
14,20212,38210,78211,34312,57611,035

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5,9144,1452,9311,7891,322628.19
Net Cash (Debt)
-2,218-928.981.822,0004,6932,878
Net Cash Growth
---99.91%-57.39%63.05%13.58%
Net Cash Per Share
-2.16-0.920.002.035.123.23
Filing Date Shares Outstanding
1,0261,026984.87985.01982.87910.76
Total Common Shares Outstanding
1,0261,026984.87985.01982.87910.76
Working Capital
2,3141,6791,7903,1335,4313,843
Book Value Per Share
5.795.885.957.269.678.72
Tangible Book Value
5,4025,4715,3396,6049,4037,680
Tangible Book Value Per Share
5.275.335.426.709.578.43
Buildings
-1,4251,3791,419-891.83
Machinery
-2,1612,0221,9211,5221,419
Construction In Progress
-2,5721,8591,3251,048801.93
Leasehold Improvements
----65.57-